Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up

Giornale Italiano di Cardiologia

Volumn 29, Issue 6, 1999, Pages 637-646

  Scardi, Sabino ^a   Mazzone, Carmine ^b   Pandullo, Claudio ^a   Goldstein, Daniela ^a   Di Lenarda, Andrea ^a   Chersevani, Dorita ^a  

^a Cardiovascular Center   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Atrial fibrillation; Thromboemboly

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SUDDEN DEATH; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0033023925     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. PRYSTOWSKY EN, BENSON CD, FUSTER V, ET AL: Management of patients with atrial fibrillation. AHA Medical Scientific Statement. Circulation 1996; 93: 1262-1277.
2. BENJAMIN EJ, WOLF PA, D'AGOSTINO RB, ET AL: Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation 1998; 98: 946-952.
3. ALBERS GW: Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med 1994; 154: 1443-1458.
4. ATRIAL FIBRILLATION INVESTIGATORS: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
5. SCARDI S, MAZZONE C, GOLDSTEIN D, ET AL: TASAF: Trieste Area Study on non-rheumatic Atrial Fibrillation. The results of the enrolled study population. G Ital Cardiol 1995; 25: 173-182.
6. CAMERON A, SCHWARTZ MJ, KRONMAL RA, ET AL: Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry). Am J Cardiol 1988; 61: 714-717.
7. HOFFMAN T, MEINERTZ T, KASPER W, ET AL: Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 1988; 116: 1455-1463.
8. ROMEO F, PELLICCIA F, CIANFROCCA C, CRISTOFANI R: Predictors of sudden death in idiopathic cardiomyopathy. Am J Cardiol 1989; 63: 138-140.
9. UNVERFERTH DV, MAGORIEN RD, MOESCHBERGER ML: Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1990; 65: 903-908.
10. LAKE FR MC CALL MG, CULLEN KJ, ET AL: Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 1989; 19: 321-326.
11. KRAHN AD, MANFREDA J, TATE RB, ET AL: The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba follow-up study. Am J Med 1995; 98: 476-484.
12. FLEGEL KM, SHIPLEY MJ, ROSE G: Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987; 1: 526-529.
13. WOLF PA, KANNEL WB, BAKER CS, ET AL: Increased mortality, stroke and medical costs imposed by atrial fibrillation (abstract). J Am Coll Cardiol 1996; 27 (Suppl. A): 312.
14. ONUNDARSON PT, THORGEIRSSON G, JONMUNDSSON E, ET AL: Chronic atrial fibrillation-epidemiologic features and 14 year follow-up. A case control study. Eur Heart J 1987; 3: 521-527.
15. GAJEWSKI J, SINGER RB: Mortality in an insured population with atrial fibrillation. JAMA 1980; 245: 1540-1545.
16. GODTFREDSEN J: Atrial fibrillation. Etiology, course and prognosis. A follow-up study of 1212 cases. Doctor of Medicine thesis. Munksgaard, University of Copenhagen, 1975.
17. MIDDLEKAUFF HR, STEVENSON WG, STEVENSON LW: Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991; 84: 40-48.
18. DRIES DL, GERSH BJ, DOMANSKI MJ, ET AL: Atrial fibrillation in mild to moderate heart failure is independently associated with progressive pump failure death. J Am Coll Cardiol 1998; 31 (Suppl A): 219A.
19. DEMIROVIC J, MYERBURG RJ: Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis 1994; 37: 39-48.
20. FLAKER GC, BLACKSHEAR JL, MCBRIDE R, ET AL: Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20: 527-532.
21. PAI RG, RAWLES JM: The QT interval in atrial fibrillation. Br Heart J 1989; 61: 510-513.
22. WOLF PA, DAWBER TR, THOMAS JR HE, ET AL: Epidemiological assessment of chronic atrial fibrillation and risk of stroke. The Framingham Study. Neurology 1978; 28: 973-977.
23. HINTON RG, KISTLER JP, FALLON JT, ET AL: Influence of aetiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977; 40: 509-513.
24. SAGE JI, VAN VITERT RL: Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Stroke 1983; 14: 537-540.
25. HART RG, COULL BM, HART D: Early recurrent embolism associated with non-valvular atrial fibrillation, a retrospective study. Stroke 1983; 14: 688-693.
26. WOLF PA, KANNEL WB, MCGREER DL, ET AL: Duration of atrial fibrillation and imminence of stroke: The Framingham Study. Stroke 1983; 14: 664-667.
27. GIANSANTE C, LA VERDE R, PANDULLO C, ET AL: D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. Arterioscler Thromb Vasc Biol 1997; 17: 1320-1324.
28. PANDULLO C, GIANSANTE C, FIOTTI N, ET AL: Transesophageal echocardiography and coagulation indicators in patients with nonvalvular atrial fibrillation: a prospective 3-year study. J Am Coll Cardiol 1998; 31 (Suppl A): 301A.
29. FIHN SD: Aiming for safe anticoagulation. N Engl J Med 1995; 333: 54-55.
30. FRENCH STUDY OF AORTIC PLAQUES IN STROKE GROUP: Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996; 334: 1216-1221.
31. DRESSLER FA, CRAIG WR, CASTELLO R: Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol 1998; 31: 134-139.